Provided by Tiger Trade Technology Pte. Ltd.

NT PHARMA

0.450
-0.025-5.26%
Volume:230.00K
Turnover:105.05K
Market Cap:427.05M
PE:-10.66
High:0.475
Open:0.475
Low:0.450
Close:0.475
52wk High:1.350
52wk Low:0.300
Shares:949.00M
HK Float Shares:949.00M
Volume Ratio:0.53
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.042
ROE:-8.14%
ROA:-1.76%
PB:-3.29
PE(LYR):-10.66
PS:10.22

Loading ...

Insiders Made Right Decision To Sell As China NT Pharma Group Dips 21%

Simply Wall St.
·
Apr 17

NT Pharma appoints Lou Yongbin as Non-executive Director, bolstering AI healthcare pivot

Bulletin Express
·
Apr 13

NT PHARMA (01011) Appoints Lou Yongbin as Non-Executive Director

Stock News
·
Apr 13

China NT Pharma appoints Lou Yongbin as non-executive director

Reuters
·
Apr 13

NT Pharma Issues 274.75 Million New Shares at HK$0.45, Expanding Issued Capital to 948.99 Million

Bulletin Express
·
Apr 02

China NT Pharma FY25 net loss narrows 50.8% to RMB 26 million

Reuters
·
Apr 01

NT PHARMA Reports Annual Results: Shareholder Loss Narrows by 51.2% to 26.041 Million Yuan

Stock News
·
Apr 01

NT PHARMA Forecasts Net Loss Between RMB 10.9 Million and RMB 15.9 Million for 2025 Fiscal Year

Stock News
·
Mar 30

China NT Pharma expects 2025 net loss RMB 11 million–16 million, narrowed by HKD 15 million gain

Reuters
·
Mar 30

NT Pharma cuts 2025 loss estimate after HK$15.40 million one-off gain from debt-for-equity swap

Bulletin Express
·
Mar 30

China NT Pharma Group- Expected Loss for Year Further Reduced by HK$15.4 Mln as Compared With Prior Guidance

THOMSON REUTERS
·
Mar 30

NT Pharma issues 274.75 million consideration shares for acquisition, expanding share base by 40.75%

Bulletin Express
·
Mar 25

NT PHARMA Finalizes Acquisition of Majority Stake in Zhejiang Kangyuan Medical Equipment

Stock News
·
Mar 25

NT Pharma completes full acquisition of three target companies, issues 274.75 million new shares at HK$0.45

Bulletin Express
·
Mar 25

China NT Pharma Group completes acquisition of three target companies; issues 274.8 million shares at HK$0.45

Reuters
·
Mar 25

NT Pharma (01011): Board Meeting Set for 31 Mar 2026 to Approve FY2025 Results and Final Dividend Proposal

Bulletin Express
·
Mar 18

China NT Pharma schedules board meeting to approve annual results and consider final dividend

Reuters
·
Mar 18